Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 NOVOZYMES A/S/SBioNTechNeurocrine BiosciencesBIO-TECHNEargenx
Price Information
Current Price$58.24$63.27$125.37$269.18$228.72
52 Week RangeHoldHoldBuyBuyBuy
Beat the Market™ Rank
Overall Score0.
Analysis Score0.
Community Score1.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationHoldHoldBuyBuyBuy
Consensus Price TargetN/A$43.56$127.76$245.50$220.40
% Upside from Price TargetN/A-31.16% downside1.91% upside-8.80% downside-3.64% downside
Trade Information
Market Cap$17.30 billion$14.32 billion$11.64 billion$10.29 billion$10.75 billion
Average Volume28,5192,065,663923,950233,358166,108
Sales & Book Value
Annual Revenue$2.28 billion$121.63 million$788.10 million$714.01 million$78.17 million
Price / Sales7.58117.7014.7714.41137.55
Cashflow$1.72 per shareN/A$0.68 per share$5.97 per shareN/A
Price / Cash33.83N/A183.8645.10N/A
Book Value$6.10 per share$2.44 per share$6.92 per share$30.78 per share$30.88 per share
Price / Book9.5525.9318.128.757.41
Net Income$511 million$-200,540,000.00$37.01 million$96.07 million$-182,520,000.00
Trailing P/E Ratio36.17N/A68.1456.91N/A
Forward P/E Ratio33.66N/A26.9659.29N/A
P/E Growth$26.03N/AN/A$9.89N/A
Net MarginsN/AN/A19.90%24.77%N/A
Return on Equity (ROE)N/AN/A37.53%13.04%N/A
Return on Assets (ROA)N/AN/A18.29%8.13%N/A
Annual Payout$0.52N/AN/A$1.28N/A
Dividend Yield0.89%N/AN/A0.48%N/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/A33.68%N/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity RatioN/AN/A0.71%0.37%N/A
Current RatioN/A3.47%6.90%4.69%8.58%
Quick RatioN/A3.40%6.75%3.74%8.58%
Ownership Information
Institutional Ownership Percentage0.13%2.92%96.75%95.68%54.53%
Insider Ownership PercentageN/AN/A4.30%4.20%N/A
Shares Outstanding297.00 million226.26 million92.86 million38.22 million47.01 million
Next Earnings Date8/13/2020 (Estimated)N/A8/3/2020 (Estimated)8/4/2020 (Estimated)N/A
OptionableNot OptionableNot OptionableOptionableOptionableOptionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.